Marc A. Judson

Jul 2, 2024 | sciencedirect.com | Sara Barmettler |Fabian Hauck |Marc A. Judson |Darren E. Gemoets

The field of artificial intelligence (AI) witnessed a meteoric rise with deep learning’s triumph in the ImageNet Challenge,1 followed by a series of groundbreaking developments, including the inception of reinforcement learning, AlphaGo’s remarkable victories against human,2,3 advancements in transformer models4 for natural language processing (NLP), the introduction of Google’s pre-trained model Bidirectional Encoder Representations from Transformers (BERT),5 and the global sensation caused...

Feb 22, 2024 | mdpi.com | Sooyeon Kwon |Marc A. Judson |In Albany

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jan 18, 2024 | chestmed.theclinics.com | Robert P. Baughman |Elyse E. Lower |Marc A. Judson

This site can’t provide a secure connection acw.secure.jbs.elsevierhealth.com uses an unsupported protocol.

Dec 17, 2023 | resmedjournal.com | Marc A. Judson

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Dec 6, 2023 | chestmed.theclinics.com | Robert P. Baughman |Marc A. Judson

Sarcoidosis is one of the most common idiopathic interstitial lung diseases treated by health care providers. While it affects the lungs in over 90% of cases, it can affect any part of the body. The multiorgan involvement of sarcoidosis impacts the approach to both diagnosis and treatment. This issue of Clinics of Chest Medicine contains several articles concerning pulmonary aspects of the disease.